- Industry Solutions
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
- Right block
- Industry Solutions
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
- Right block
- Products
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
- Right block
- Services & Support
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
- Right block
- Resources
- Resources
2026 State of Revenue Report
What’s happening in revenue management and compliance this year?
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
- Right block
- Resources
- Company
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
- Right block
Contact Us
.
- Products
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
- Right block
- Services & Support
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
- Right block
- Resources
- Resources
2026 State of Revenue Report
What’s happening in revenue management and compliance this year?
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
- Right block
- Resources
- Company
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
- Right block
- Industry Solutions
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
- Right block
- Products
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
- Right block
- Services & Support
Services & Support
To ensure you get the most out of your Model N investment Model N provides a complete set of professional Customer Success, Services and Support offerings designed to further your business and IT success.
- Right block
- Resources
- Resources
2026 State of Revenue Report
What’s happening in revenue management and compliance this year?
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
- Right block
- Resources
- Company
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
- Right block
Quick Links
Back to FAQs
What problem does 340B Vigilance solve?
Pharma manufacturers face the risk of paying unauthorized or duplicate rebates when prescriptions acquired at 340B discounted prices are also processed for additional rebates like Medicaid rebates.
340B Vigilance helps reduce revenue loss by:
- Identifying duplicate discount occurrences
- Flagging ineligible rebate submissions before payment
- Ensuring compliance with 340B program policies
This helps organizations optimize revenue and avoid costly errors or penalties.
Related Questions
Contact Sales
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
Our Customers Include:
Thank you for reaching out.
We look forward to responding within one business day.